Nuvation Bio NUVB
$3.80 −$0.01 (-0.26%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $3.80 0.00%
Open$3.77
Prev close$3.81
Day range$3.72 – $3.91
Volume6.85M
Market cap$1.34B
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±7.9%last 7 reports
Closed higher2 of 729% of the time
Best reaction+9.5%
Worst reaction-25.3%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | Pre Market | ±23.6% | -4.08% | Within range |
| 2026/Q1 | 4 May 2026 | After Market | ±18.1% | +9.52% | Within range |
| 2025/Q4 | 2 Mar 2026 | After Market | ±30.4% | -25.34% | Within range |
| 2025/Q3 | 3 Nov 2025 | After Market | ±24.2% | -6.58% | Within range |
| 2025/Q2 | 7 Aug 2025 | Pre Market | ±18.7% | -0.43% | Within range |
| 2025/Q1 | 7 May 2025 | After Market | ±24.5% | +2.94% | Within range |
| 2022/Q1 | 9 May 2022 | None | – | -6.21% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$44.95M+242.6% YoY
Operating profit-$42.21M+25.2% YoY
Net profit-$41.90M+24.9% YoY
Diluted EPS-$0.12+25.0% YoY
Free cash flow-$40.15M+34.1% YoY
Operating cash flow-$38.56M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin85.8%
Operating margin-61.2%
Net margin-67.4%
Return on equity-49.1%
Return on assets-19.7%
Return on invested capital-28.7%
Current ratio7.45
Liabilities / assets70.7%
Cash & investments$663.37M
Total debt$299.66M
Net cash (debt)$363.72M
No comments yet — be the first to weigh in on NUVB.
Sign in to join the discussion.